16-77193495-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014940.4(MON1B):c.193C>A(p.Gln65Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000829 in 1,447,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014940.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MON1B | NM_014940.4 | c.193C>A | p.Gln65Lys | missense_variant | 3/6 | ENST00000248248.8 | NP_055755.1 | |
MON1B | NM_001286639.2 | c.149-840C>A | intron_variant | NP_001273568.1 | ||||
MON1B | NM_001286640.2 | c.38-840C>A | intron_variant | NP_001273569.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MON1B | ENST00000248248.8 | c.193C>A | p.Gln65Lys | missense_variant | 3/6 | 1 | NM_014940.4 | ENSP00000248248.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000249 AC: 6AN: 240968Hom.: 0 AF XY: 0.0000308 AC XY: 4AN XY: 129746
GnomAD4 exome AF: 0.00000829 AC: 12AN: 1447218Hom.: 0 Cov.: 31 AF XY: 0.0000111 AC XY: 8AN XY: 718214
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2024 | The c.193C>A (p.Q65K) alteration is located in exon 3 (coding exon 2) of the MON1B gene. This alteration results from a C to A substitution at nucleotide position 193, causing the glutamine (Q) at amino acid position 65 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at